Penn State researchers awarded $2.86M to develop a new oral antibiotic to treat multidrug-resistant gonorrhea
by Press Release from Outbreak News Today on (#50ZMR)
Up to $2.86M has been awarded to a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic. The research team includes Penn State Professor of Biochemistry and Molecular Biology Kenneth Keiler, the U.S.-based ["]
The post Penn State researchers awarded $2.86M to develop a new oral antibiotic to treat multidrug-resistant gonorrhea appeared first on Outbreak News Today.